Constitutive modulation of Raf-1 protein kinase is associated with differential gene expression of several known and unknown genes

Molecular Medicine

Volumn 3, Issue 10, 1997, Pages 674-685

  Patel, Sonal ^a   Wang, Fuh Han ^a   Whiteside, Theresa L ^b   Kasid, Usha ^a  

^a GEORGETOWN UNIVERSITY   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN KINASE; PROTEIN SERINE THREONINE KINASE;

AMINO TERMINAL SEQUENCE; ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; DELETION MUTANT; EFFECTOR CELL; ENZYME ACTIVATION; ENZYME MODIFICATION; GENE EXPRESSION REGULATION; GENE MUTATION; GENETIC ANALYSIS; HOUSEKEEPING GENE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTO ONCOGENE; SIGNAL TRANSDUCTION;

EID: 0031441241     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03401706     Document Type: Article

References (48)

1. Heidecker G, Kolch W, Morrison D, Rapp UR. (1992) The role of Raf-1 phosphorylation in signal transduction. Adv. Cancer Res. 58: 53-73.
2. Devary Y, Gottlieb RA, Smeal T, Karin M. (1992) The mammalian ultraviolet response is triggered by activation of Src tyrosine kinases. Cell 71: 1081-1091.
3. Howe LR, Leevers SJ, Gomez N, Nakielny S, Cohen P, Marshall CJ. (1992) Activation of the MAP kinase pathway by the protein kinase Raf. Cell 71: 335-342.
4. Dent P, Haser W, Haystead TAG, Vincent LA, Roberts TM, Sturgill TW. (1992) Activation of mitogen-activated protein kinase kinase by v-Raf in NIH 3T3 cells and in vitro. Science 257: 1404-1407.
5. Finco T, Baldwin A. (1993) κB site-dependent induction of gene expression by diverse inducers of nuclear factor κB requires Raf-1. J. Biol. Chem. 268: 17676-17679.
6. Marshall CJ. (1995) Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80: 179-185.
7. Kasid U, Suy S, Dent P, Ray S, Whiteside TLW, Sturgill T. (1996) Raf activation by ionizing radiation. Nature 382: 813-816.
8. Suy S, Anderson WB, Dent P, Chang E, Kasid U. (1997) Association of Grb2 with Sos and Ras with Raf-1 upon gamma irradiation of breast cancer cells. Oncogene 15: 53-61.
9. Stanton VP, Nichols DW, Laudano AP, Cooper GM. (1989) Definition of the human raf amino-terminal regulatory region by deletion mutagenesis. Mol. Cell. Biol. 9: 639-647.
10. Heidecker G, Huleihel M, Cleveland JL, et al. (1990) Mutational activation of c-raf-1 and definition of the minimal transforming sequence. Mol. Cell. Biol. 10: 2503-2512.
11. Kasid U, Pfeifer A, Weichselbaum RR, Dritschilo A, Mark GE. (1987) The raf oncogene is associated with a radiation-resistant human laryngeal cancer. Science 237: 1039-1041.
12. Patel B, Ray S, Whiteside TLW, Kasid U. (1997) Constitutive activation of Raf-1 correlates with morphological transformation and abrogation of tyrosine phosphorylation of distinct sets of proteins in human squamous carcinoma cells. Mol. Carcinog. 18: 1-6.
13. Kyriakis JM, App H, Zhang XF, et al. (1992) Raf-1 activates MAP kinase-kinase. Nature 358: 417-421.
14. Bruder JT, Heidecker G, Rapp UR. (1992) Serum-, TPA-, and Ras-induced expression from AP-1/Ets-driven promoters requires Raf-1 kinase. Genes Dev. 6: 545-556.
15. Qureshi SA, Rim M, Bruder JT, et al. (1991) An inhibitory mutant of c-raf-1 blocks v-src-induced activation of the egr-1 promoter. J. Biol. Chem. 266: 20594-20597.
16. Shengfeng Li, Sedivy JM. (1993) Raf-1 protein kinase activates the NF-κB transcription factor by dissociating the cytoplasmic NF-κB-1κB complex. Proc. Natl. Acad. Sci. USA 90: 9247-9251.
17. Kasid U, Pfeifer A, Brennan T, Beckett M, Weichselbaum RR, Dritschilo A, Mark G. (1989) Effect of antisense c-raf-1 on tumor-igenicity and radiation sensitivity of a human squamous carcinoma. Science 243: 1354-1356.
18. Monia B, Johnston JF, Geiger T, Muller M, Fabbro D. (1996) Antitumor activity of a phosphorothioate antisense oligodeoxynucleotide targeted against c-raf kinase. Nature Med. 2: 668-675.
19. Soldatenkov VA, Dritschilo A, Wang F-H, Olah Z, Anderson WB, Kasid U. (1997) Inhibition of Raf-1 protein kinase by antisense phosphorothioate oligodeoxynucleotide is associated with sensitization of human laryngeal squamous carcinoma cells to gamma radiation. Cancer J. Sci. Am. 3: 13-20.
20. Gokhale PC, Soldatenkov V, Wang F-H, Rahman A, Dritschilo A, Kasid U. (1997) Antisense raf oligodeoxyribonucleotide is protected by liposomal encapsulation and inhibits Raf-1 protein expression in vitro and in vivo: Implication for gene therapy of radioresistant cancer. Gene Therapy In press.
21. Wang HG, Rapp UR, Reed JC. (1996) Bcl-2 targets the protein kinase Raf-1 to mitochondria. Cell 87: 629-638.
22. Liang P, Pardee AB. (1992) Differential display of eukaryotic mRNA by means of the polymerase chain reaction. Science 257: 967-971.
23. Patel S, Wang F-H, Whiteside TL, Kasid U. (1997) Identification of seven differentially displayed transcripts in human primary and matched metastatic head and neck squamous carcinoma cell lines: Implications in metastasis and/or radiation response. Eur J Cancer B Oral Oncol. 33: 197-203.
24. Heo DS, Synderman C, Gollin SM, et al. (1989) Biology, cytogenetics, and sensitivity to immunological effector cells of new head and neck squamous cell carcinoma lines. Cancer Res. 49: 5167-5175.
25. Maniatis T, Fritsch EF, Aambroook J. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1982.
26. Rubin H, Wang Z-M, Nickbarg EB, et al. (1990) Cloning, expression, purification and biological activity of recombinant native and variant human α1-antichymotrypsins. J. Biol. Chem. 265: 1199-1207.
27. Uetsuki T, Naito A, Nagata S, Kaziro Y. (1989) Isolation and characterization of the human chromosomal gene for polypeptide chain elongation factor-1α. J. Biol. Chem. 264: 5791-5798.
28. Tewari ST, Qian Y, Thornton RD, et al. (1994) Molecular cloning and sequencing of a human cDNA encoding ornithine decarboxylase antizyme. Bichim. Biophys. Acta 1209: 293-295.
29. Rubin H. (1992) The biology and biochemistry of antichymotrypsin and its potential role as a therapeutic agent. Biol. Chem. Hoppe-Seyler 373: 497-502.
30. Lotem J, Sachs L. (1996) Differential suppression by protease inhibitors and cytokines of apoptosis induced by wild-type p53 and cytotoxic agents. Proc. Natl. Acad. Sci. USA 93: 12507-12512.
31. Rubin H. (1996) Serine protease inhibitors (SERPINS) Where mechanism meets medicine. Nature Med. 2: 632-633.
32. s6k activation. J. Biol. Chem. 39: 23650-23652.
33. Stryer L. (1995) Biochemistry. W.H. Freeman, New York.
34. Torroni A, Stepien G, Hodge JA, Wallace DC. (1990) Neoplastic transformation is associated with coordinate induction of nuclear and cytoplasmic oxidative phosphorylation genes. J. Biol. Chem. 265: 20589-20593.
35. Wang F-L, Wang Y, Wong W-K, Liu Y, Addivinola FJ, Liang P, Chen LB, Kantoff PW, Pardee AB. (1996) Two differentially expressed genes in normal and human prostate tissue and in carcinoma. Cancer Res. 56: 3634-3637.
36. Mullauer L, Suzuki H, Fujita M, Katabami M, Kuzumaki N. (1991) Identification of genes that exhibit increased expression after flat reversion of NIH/3T3 cells transformed by human activated Ha-ras oncogene. Cancer Lett. 59: 37-43.
37. Kumazawa Y, Schwartzbach CJ, Liao HX, et al. (1991) Interactions of bovine mitochondrial phenylalanyl-tRNA with ribosomes and elongation factors from mitochondria and bacteria. Biochim. Biophys. Acta 1090: 167-172.
38. Taniguchi S, Miyamoto S, Sadano H, Kobayashi H. (1991) Rat elongation factor 1α: Sequence of cDNA from a highly metastatic fos-transferred cell line. Nucl. Acids Res. 19: 6949.
39. Koch I, Hofschneider PH, Lottspeich F, Eckerskorn C, Koshy R. (1990) Tumor-related expression of a translation-elongation factor-like protein. Oncogene 5: 839-843.
40. Tatsuka M, Mitsui H, Wada M, Nagata A, Nojima H, Okayama H. (1992) Elongation factor-1α gene determines susceptibility to transformation. Nature 359: 333-336.
41. Wakabayashi-Ito N, Nagata S. (1994) Characterization of the regulatory elements in the promoter of the human elongation factor-1α gene. J. Biol. Chem. 269: 29831-29837.
42. Heller JS, Fong WF, Canellakis ES. (1976) Induction of a protein inhibitor to ornithine decarboxylase by the end products of its reaction. Proc. Natl. Acad. Sci. USA 73: 1858-1862.
43. Heby O, Persson L. (1990) Molecular genetics of polyamine synthesis in eukaryotic cells. Trends Biochem. Sci. 15: 153-158.
44. Auvinen M, Paasinen A, Andersson LC, Holtta E. (1992) Ornithine decarboxylase activity is critical for cell transformation. Nature 360: 355-358.
45. Auvinen M, Paasinen-Sohns A, Hirai H, Andersson LC, Holtta E. (1995) Ornithine decarboxylase and ras induced cell transformations: Reversal by protein tyrosine kinase inhibitors and role of pp130CAS. Mol. Cell Biol. 15: 6513-6525.
46. Manni A, Wechter R, Gilmour S, Verderame MF, Mauger D, Demers LM. (1997) Ornithine decarboxylase overexpression stimulates mitogen-activated protein kinase and anchorage-independent growth of human breast epithelial cells. Int. J. Cancer 70: 175-182.
47. Murakami Y, Matsufuji S, Miyazaki Y, Hayashi SI. (1994) Forced expression of antizyme abolishes ornithine decarboxylase activity, suppresses cellular levels of polyamines and inhibits cell growth. Biochem. J. 304: 183-187.
48. Zhang H, Zhang R, Liang P. (1996) Differential screening of gene expression difference enriched by differential display. Nucl. Acids Res. 24: 2454-2455.